Pentetrazol
- Level
- Commodity
- Parent
- 51161700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161718This classification denotes a convulsant and gaba antagonist with the molecular formula C6H10N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WM5Z385K7T, chemically known as 7,8,9,10-tetrazabicyclo(5.3.0)-8,10-decadiene but generally known as pentetrazol, which bears US NIH Compound Identifier 5917. European Medicines Agency schedules Pentetrazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09690MIG. World Health Organization schedules pentetrazol in its Anatomical Therapeutic Chemical (ATC) Classification. PENTETRAZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentetrazol under HS 29339990 and SITC 51577. As of Q4 2014, PENTETRAZOL remains the US FDA Preferred Term for this commodity. Pentetrazol bears US NLM identifiers UMLS ID C0030903 and NCI Concept Code C81054. SMILES: C1CCC2=NN=NN2CC1.
Same parent
Under 51161700 · 27Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.